Myelofibrosis Treatment Market by Diagnosis Type (Gene Mutation Analysis, Bone Marrow biopsy, Imaging Test, and Blood Tests), by Treatment Type (Chemotherapy, Blood Transfusions, Stem Cell Transplant, Splenectomy, Radiation Therapy, and Others), by Drug Type (Hydroxyurea, Immunomodulators, JAK Inhibitor, and Others), and by End-User (Hospitals, Clinics, and Bone Marrow Transplant Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Global myelofibrosis treatment market expected to generate revenue of around USD 971.5 million by end of 2024, growing at CAGR of 6.73% between 2018 and 2024. Myelofibrosis is rare bone marrow cancer in which normal bone marrow tissues get changed with scarred tissue which reduces the production of blood cells and increases the production of mutated cells.

11-Jul-2018 | Number of pages: 110 | Report Code: ZMR-3210 | Report Format : | Status : Published

Analysis

Myelofibrosis is a bone marrow cancer or a serious type of leukemia which affects the normal production of blood cells resulting in weakness, anemia, fatigue, and often enlarged spleen. This disease is caused due to the genetic mutation in blood stem cells. These mutated cells keep on dividing themselves which leads to the reduction of red blood cells and can lead to anemia. These genetic mutations in the cells can be caused by various factors such as exposure to radiation, certain chemicals such as benzene or toluene, and other blood cell-related disorders. This disease can be diagnosed by physical examination, blood tests, imaging tests, and bone marrow examination to confirm the presence of disease. Various symptoms such as feeling tired and weak, shortness of breath, fever, easy bleeding, a feeling of pain in bones and joint are observed in the patients of myelofibrosis. This condition can be treated by different therapies, medication, or stem cell transplant.

The epidemiology of myelofibrosis is increasing in the developing economies which results in the increase in demand for treatment options over the forecast period. There are various companies conducting research studies and investing a lot of money in R&D for the development of myelofibrosis drug. There are various drugs which are currently developed by different companies such as CYT387 which is being developed by Gilead Sciences Inc.; CTI BioPharma is trying to modify Pactritinib so that it can be used for the treatment of myelofibrosis and others. Increase in genetic disorders, smoking, reimbursement conditions, and living conditions are also expected to support the growth of myelofibrosis treatment market over the forecast period.

Global Myelofibrosis Treatment Market

Based on the diagnosis type, the myelofibrosis treatment market is segmented into gene mutation, bone marrow biopsy, an imaging test, and blood tests. Treatment type segmentation includes chemotherapy, blood transfusions, stem cell transplant splenectomy, radiation therapy, and others. Based on drug type, the myelofibrosis market is segmented into hydroxyurea, immunomodulators, JAK inhibitors, and others. On the basis of the end user, the myelofibrosis treatment market is segmented into hospitals, clinics, and bone marrow transplant centers.

North America is expected to remain the dominant region over the forecast period which is closely followed by Europe. Due to an increase in the prevalence of myelofibrosis in these regions and an increase in R&D for drug development are aspects expected to support the growth of the myelofibrosis treatment market. The Asia Pacific is expected to be the third largest growing region for the myelofibrosis treatment market due to increase in healthcare facilities, increase in disposable income and an increase in the prevalence of disease. Latin America and the Middle East and Africa are expected to grow moderately over the forecast period.

Some of the key players in myelofibrosis treatment market include Eli Lilly and Company, Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Incyte Corporation, Merck & Co., Bristol-Myers Squibb Company, Novartis AG, Amgen Inc., and Celgene Corporation, among others.


Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Global Remdesivir Market - by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Free Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.